LPN INTENSIVE CALCULATIONS�� DRUG INTERACTIONS FOR GPHC EXAM ��� INTENSIVE GPHC Exam revision programme
LONDON PHARMACIST NETWORK (LPN)
UK’S MOST INTENSIVE REVISION PROGRAMME
DRUG INTERACTIONS FOR GPHC EXAM
SEROTONIN SYDROME
Can occur if patients take one or more drugs which can increase serotonin levels.
Ward Based Management
• Organize immediate medical review • Medications should be reviewed • Fluids should be given for dehydration • Cool patient down • Physical observations: Heart rate, Blood Pressure ,Temperature, Respiratory rate.
QT PROLONGATION
Can occur if patients take one or more drugs which can prolong QT interval.
• Consider the risk of QT prolongation when starting a new medicine (if unsure of medicine related risk contact prescriber for advice). Assess patient’s risk factors for QT prolongation. Avoid QT prolonging drugs in patients with congenital long QT syndrome. Correct any modifiable risk factors such as electrolyte disturbance.
Where a patient has risk factors and / or is prescribed an interacting medicine, the first line option is to change to an alternative drug that is not known to prolong the QT interval whenever possible.
Increased Bleeding
Can occur if patients take one or more drugs which can increase bleeding.
• Check Hemoglobin levels, check platelets levels, Where a patient has risk factors and / or is prescribed an interacting medicine, the first line option is to change to an alternative drug that is not known to increase bleeding, if possible, give an antidote wherever possible, Local hemostatic measures, Mechanical compression, Consider surgical intervention.
Increased Blood clots
Can occur if patients take one or more drugs which can increase blood clot formation. The clot may break off and travel within the body to cause further damage such as stroke, Pulmonary embolism, DVT etc.
• Systemic thrombolysis – a clot-busting medicine is given. E.g. heparins. Mechanical thrombectomy- surgery.
INCREASED MYOPATHY
Can occur if patients take one or more drugs alongside STATINS which can increase the risk of myopathy, muscle breakdown and rhabdomyolysis.
• Check creatinine kinase level
Egfr reduction
Can occur if patients take one or more drugs which can reduce renal function. Renal impairment can lead increased toxicity of certain drugs. E.g. lithium, methotrexate, DOACs, SGLT2 inhibitors.
• Stop drugs affecting renal function.
ENZYME INDUCTION & INHIBITION
BETA AGONIST & BETA BLOCKERS
An interaction can occur if patients take a beta blocker and a beta agonist together or drugs to treat asthma, COPD etc.
• Stop drugs causing constriction of airways if possible.
QT PROLONGATION DRUGS
antiarrhythmics, antipsychotics, antidepressants, antibiotics, antihistamines, antiemetics, antifungals, and certain high‑risk agents such as methadone and quinine.
A mnemonic that captures these high‑yield categories is: 🧠 Mnemonic: “A BAD MAPS”
- A — Antiarrhythmics
Includes class IA (quinidine, procainamide, disopyramide) and class III (amiodarone, sotalol).
- B — Broad‑spectrum antibiotics
Especially macrolides (erythromycin, clarithromycin) and fluoroquinolones.
- A — Antidepressants
SSRIs (citalopram, escitalopram), TCAs (amitriptyline, imipramine).
- D — Dopamine‑blocking antipsychotics
Haloperidol, quetiapine, risperidone, thioridazine.
- M — Methadone & other high‑risk medicines
Methadone and quinine appear in UK lists of QT‑prolonging drugs.
- A — Antihistamines
Diphenhydramine, loratadine, terfenadine (historically significant).
- P — Potent antiemetics
Ondansetron and metoclopramide.
- S — Systemic antifungals
Azoles such as fluconazole and voriconazole.
THE END